Knockdown of L1CAM significantly reduces metastasis in a xenograft model of human melanoma: L1CAM is a potential target for anti-melanoma therapy.
Finding additional functional targets for combination therapy could improve the outcome for melanoma patients. In a spontaneous metastasis xenograft model of human melanoma a shRNA mediated knockdown of L1CAM more than sevenfold reduced the number of lung metastases after the induction of subcutaneo...
Main Authors: | Ann-Kathrin Ernst, Annika Putscher, Timur R Samatov, Anna Suling, Vladimir V Galatenko, Maxim Yu Shkurnikov, Evgeny N Knyazev, Alexander G Tonevitsky, Thomas Haalck, Tobias Lange, Hanna Maar, Jennifer Schröder-Schwarz, Kristoffer Riecken, Udo Schumacher, Daniel Wicklein |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5809060?pdf=render |
Similar Items
-
Expression of EpCAM in uveal melanoma
by: Odashiro Alexandre N, et al.
Published: (2006-11-01) -
CEACAM1 promotes melanoma metastasis and is involved in the regulation of the EMT associated gene network in melanoma cells
by: Daniel Wicklein, et al.
Published: (2018-08-01) -
Antibody directed against human YKL-40 increases tumor volume in a human melanoma xenograft model in scid mice.
by: Johannes Salamon, et al.
Published: (2014-01-01) -
EpCAM knockdown alters microRNA expression in retinoblastoma--functional implication of EpCAM regulated miRNA in tumor progression.
by: Madhu Beta, et al.
Published: (2014-01-01) -
Intracellular domain of L1CAM contributesto L1CAM-mediated OSCC tumor progression
by: Ya-Yun Huang, et al.
Published: (2012)